Theophylline-citric acid co-crystals easily induced by DSC-FTIR microspectroscopy or different storage conditions

Asian Journal of Pharmaceutical Sciences

Volumn 8, Issue 1, 2013, Pages 19-27

  Lin, Hong Liang ^a   Hsu, Po Chun ^a   Lin, Shan Yang ^a  

^a YUANPEI UNIVERSITY   (Taiwan)

Author keywords

Anhydrous citric acid; Anhydrous theophylline; Co crystal; DSC FTIR; Ground mixture; Storage condition

Indexed keywords

CITRIC ACID; THEOPHYLLINE;

ARTICLE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; FOURIER TRANSFORM INFRARED MICROSPECTROSCOPY; HEATING; INFRARED SPECTROSCOPY; LIQUID; MELTING POINT; MOLECULAR INTERACTION; PHASE TRANSITION; SOLID STATE; THERMOSTABILITY;

EID: 84881354832     PISSN: 18180876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajps.2013.07.003     Document Type: Article

References (34)

1. Qiao N, Li M, Schlindwein W, et al. Trappitt, Pharmaceutical cocrystals: an overview. Int J Pharm. 2011, 419: 1-11.
2. Friščić T, Jones W. Benefits of cocrystallisation in pharmaceutical materials science: an update. J Pharm Pharmacol. 2010, 62: 1547-1559.
3. Vishweshwar P, McMahon JA, Bis JA, et al. Pharmaceutical co-crystals. J Pharm Sci. 2006, 95: 499-516.
4. Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 2009, 9: 2950-2967.
5. Miroshnyk I, Mirza S, Sandler N. Pharmaceutical co-crystals-an opportunity for drug product enhancement. Expert Opin Drug Deliv. 2009, 6: 333-341.
6. Sekhon BS. Pharmaceutical co-crystals-a review. Ars Pharm. 2009, 50: 99-117.
7. Trask AV. An overview of pharmaceutical cocrystals as intellectual property. Mol Pharm. 2007, 4: 301-309.
8. Yadav AV, Shete AS, Dabke AP, et al. A novel approach to modify physicochemical properties of active pharmaceutical ingredients. Indian J Pharm Sci. 2009, 71: 359-370.
9. Ohta K, Fukuchi Y, Grouse L, et al. A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD. Respir Med. 2004, 98: 1016-1024.
10. Hansel TT, Tennant RC, Tan AJ, et al. Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease. Drugs Today (Barc). 2004, 40: 55-69.
11. Nuhoglu Y, Nuhoglu C. Aminophylline for treating asthma and chronic bstructive pulmonary disease. Expert Rev Respir Med. 2008, 2: 305-313.
12. Bán M, Bombicz P, Madarász J. Thermal stability and structure of a new co-crystal of theophylline formed with phthalic acid. J Thermal Anal Calorim. 2009, 95: 895-901.
13. Jayasankar A, Roy L, Rodríguez-Hornedo N. Transformation pathways of cocrystal hydrates when coformer modulates water activity. J Pharm Sci. 2010, 99: 3977-3985.
14. Simon PA, Terzian CG. Skin reactions to topical aminophylline. JAMA. 1995, 273: 1737-1738.
15. Zuidema J. Ethylenediamine, profile of a sensitizing excipient. Pharm Weekbl
16. Trask AV, Motherwell WD, Jones W. Physical stability enhancement of theophylline via cocrystallization. Int J Pharm. 2006, 320: 114-123.
17. Childs SL, Stahly GP, Park A. The salt-cocrystal continuum: the influence of crystal structure on ionization state. Mol Pharm. 2007, 4: 323-338.
18. Zhang GC, Lin HL, Lin SY. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process. J Pharm Biomed Anal. 2012, 66: 162-169.
19. Hsu PC, Lin HL, Wang SL, et al. Solid-state thermal behavior and stability studies of theophylline-citric acid cocrystals prepared by neat cogrinding or thermal treatment. J Solid State Chem. 2012, 192: 238-245.
20. Wu TK, Lin SY, Lin HL, et al. Simultaneous DSC-FTIR microspectroscopy used to screen and detect the co-crystal formation in real time. Bioorg Med Chem Lett. 2011, 21: 3148-3151.
21. Hsu CH, Lin SY. Rapid examination of the kinetic process of intramolecular lactamization of gabapentin using DSC-FTIR. Thermochim Acta. 2009, 486: 5-10.
22. Lin SY, Cheng WT, Wei YS, et al. DSC-FTIR microspectroscopy used to investigate the thermal-induced Intramolecular cyclic anhydride formation between Eudragit E and PVA copolymer. Polym J. 2011, 43: 577-580.
23. Wang SL, Wong YC, g WT, et al. A continuous process for solid-state dehydration, amorphization and recrystallization of metoclopramide HCL monohydrate studied by simultaneous DSC-FTIR microspectroscopy. J Thermal Anal Calorim. 2011, 104: 261-264.
24. Lin SY, Wang SL. Advances in simultaneous DSC-FTIR microspectroscopy for rapid solid-state chemical stability studies: Some dipeptide drugs as examples. Adv Drug Deliv Rev. 2012, 64: 461-478.
25. Karki S, Friscić T, Jones W, et al. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding. Mol Pharm. 2007, 4: 347-354.
26. Lu E, Rodriguez-Hornedo N, Suryanarayanan R. A rapid thermal method for cocrystal screening. Cryst Eng Comm. 2008, 10: 665-668.
27. Stevens JS, Byard SJ, Schroeder SLM. Characterization of proton transfer in co-crystals by X-ray photoelectron spectroscopy (XPS). Cryst Growth Des. 2010, 10: 1435-1442.
28. Kesavan JG, Peckt GE. Solid-state stability of theophylline anhydrous in theophylline anhydrous-polyvinylpyrrolidone physical mixtures. Drug Develop Indus Pharm. 1996, 22: 189-199.
29. Fujida T. Structural Investigation of the divalent iron and manganese complexes with citric acid by infrared spectroscopy. Chem Pharm Bull. (Tokyo) 1982, 30: 3461-3465.
30. Bichara LC, Lanús HE, Ferrer EG, et al. Vibrational study and force field of the citric acid dimer based on the SQM methodology. Adv Phys Chem. 2011, 2011: Article ID 347072.
31. 2O. Inorg Chem. 1989, 28: 719-723.
32. US FDA. Guidance for industry, ICH Q1A (R2), Stability testing of new drug substances and products, Rockville, MD, USA. 2003.
33. Huynh-Ba K. (ed.), Handbook of stability testing in pharmaceutical development: regulations, methodologies, and best practices. Springer, New York, 2008.
34. Jayasankar A, Good DJ, Rodríguez-Hornedo N. Mechanisms by which moisture generates cocrystals. Mol Pharm. 2007, 4: 360-372.